Form D — Thiogenesis Therapeutics, Corp.
0001062993-26-003123 · filed Jun 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $28,964
- Reported amount sold
- $28,964
- Minimum investment
- $0
- Investors
- 0
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Thiogenesis Therapeutics, Corp.
- CIK
- 1877778
- Entity
- Corporation
- Jurisdiction
- ONTARIO, CANADA
- Year incorporated
- —
- Address
- 4 KING STREET WEST, SUITE 401
TORONTO, Ontario, Canada M5H 1B6 - Phone
- (888) 223-9165
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Brook G. Riggins · Executive OfficerToronto, Ontario, Canada Find on LinkedIn ↗
-
Patrice Rioux · Executive OfficerToronto, Ontario, Canada Find on LinkedIn ↗
-
W. Hogan Mullally · DirectorToronto, Ontario, Canada Find on LinkedIn ↗
-
Kim Tsuchimoto · DirectorToronto, Ontario, Canada Find on LinkedIn ↗
-
Christopher Starr · DirectorToronto, Ontario, Canada Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗